On top of the NF1 alterations that we have mentioned above, amplifications in receptor tyrosine kinases (RTKs) such as EGFR (epidermal growth factor receptor) and, particularly, FGFR1 (fibroblast growth factor receptor 1) were frequent in ET-resistant BC [22]. The gene discussed is EGFR; the disease is breast cancer.